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Among the newer 8-adrenergic stimulating bronchodilators, terbutaline (Carlstrom, 1970) and salbutamol (Lewis, 1971) have been shown to be relatively selective ,-2 stimulators.
TIhe oral preparations of these two drugs have been compared by Legge, Gaddie, and Palmer (1971) , who found no significant difference between them. Freedman (1972) demonstrated that 100 ,ug salbutamol and 250 ,ug terbutaline by aerosol administration had an equipotent bronchodilating effect without any clinically important side effects.
The present study is a more detailed comparison of cardiorespiratory variables following the administration of the two substances by pressurized aerosol in twice the dosages used by Freedman.
MATERIAL
Fourteen volunteers were studied as outpatients. All were men (age 35-65, mean 55-5) shown repeatedly to have reversibility of airways obstruction by at least 20% increase in forced expiratory volume in 1 second (FEV1) after administration of a bronchodilator. All had previously taken part in similar studies. Comparisons were acceptable only if FEV1 values after placebo agreed within 10% on the test days. Initially, 18 patients were entered for the trial but 4 were excluded from future study because of wide fluctuations in baseline FEV1 measurements on the test days.
METHODS
The study was designed as a 'within-patient' trial. Each patient attended at the same time on the same day of the week on two successive weeks. At each visit baseline measurements were made 30 minutes after two inhalations from an aerosol device containing only propellant ('placebo '). Measurements were then repeated 30 minutes after two inhalations of either terbutaline or salbutamol ('active '). The order for allocation of active aerosol was randomized. At the conclusion of the trial it was found that eight patients had used terbutaline on the first visit and six had used salbutamol first. Placebo and active aerosols were indistinguishable to the patients, although the operator was aware that placebo was being used for baseline measurements. The use of propellant alone in this way compensates for any placebo effect of using an aerosol device and for any possible effect of the propellant itself. Prior to each study day the patients abstained from all their usual therapy for at least 12 hours (including corticosteroid in three patients). The dosage delivered by two activations of the aerosol devices was 500 ,ug terbutaline and 200 ,g salbutamol respectively. Measurements were made at 30 minutes because previous reports (Kennedy and Simpson, 1969; Legge et al., 1971) As the subjects were volunteer outpatients and were required to attend on at least two occasions, it was decided to avoid arterial cannulation and cardiac catheterization because of the potential risk associated with these procedures.
Oxygenated mixed venous Pco2 was measured by a 'trial and error' rebreathing equilibration method using C02/02 mixtures of known composition until an acceptable plateau was obtained on the rapid CO2 analyser tracing (Hackney, Sears, and Collier, 1958) . Blood gases and hydrogen ion concentration were measured on an IL blood gas analyser incorporating a Severinghaus type Pco2 microelectrode and a Clark type Po2 microelectrode. Samples were taken from the hyperaemic earlobe into heparinized capillary tubes and analysed promptly. The earlobe was rendered hyperaemic by vigorous massage for 3 minutes with a cream containing thurfyl nicotinate. Langlands and Wallace (1965) have reported a close correspondence between the results obtained from gas analysis of blood from the hyperaemic earlobe and that taken from the brachial artery, and Maclntyre, Norman and Smith (1968) have confirmed these findings with the technique used in the present study. Godfrey, Wozniak, Courtenay-Evans and Samuels (1971) have also confirmed the reliability of the method and have suggested correction factors. They state that no correction is required for Po2 but recommend a correction factor of 0 65 mmHg to be added to the earlobe Pco2. This correction factor has been applied to the earlobe Pco2 measurements in this study. Physiological dead space tidal volume ratio was calculated from the formula, VD/VE=1-(PECO2 / Paco2) with correction for valve box dead space of 35 ml. Cardiac oulput was derived from the Fick principle; that is QT=Vco2/CVco2-Cac02 with appropriate temperature and pressure corrections.
Blood C02 contents were derived from the tables of McHardy (1967) . Alveolar oxygen tension (PA02-was calculated from the formula, PaO2=PI02-PaCO2/R(PaCO2/R X Fio2 (l-R)). The alveolararterial oxygen tension gradient (A-aDo2) was then obtained by subtraction.
RESULTS
Mean values (± SEM) after placebo and after active aerosols are shown in the VENTILATION AND GAS EXCHANGE The increase in FEV, (+37%) after active aerosol was identical for both groups and highly significant (P<0001). VE was significantly increased after salbutamol (P<0-01). VD/VE was also increased after salbutamol whereas it was decreased after terbutaline, the difference between the means being significant (P<O01). There were no significant changes in f, Vo2 or Vco2 with either drug, but there was a significant increase in VE/VO2 after salbutamol (P<0 05).
BLOOD GASES Neither active aerosol produced any significant change in Pco2. Terbutaline did not produce any significant change in Po2 but salbutamol produced a significant fall in P02 (P<0-05). Examination of individual P02 changes showed that three patients had falls greater than 5 mmHg after salbutamol (-13, -10, -9) and two had such falls after terbutaline (-9, -7). The patient with the lowest P02 showed a fall of 4 5 mmHg (from 50 to 45 5) with salbutamol but a rise of 6 mmHg (from 54 to 60) with terbutaline. There were no significant differences in A-aDO2 with either drug.
CARDIAC OUTPUT Accepting the well-known limitations of the indirect Fick CO2 method, the use of which in similar patients with increased metabolic rates is supported by Warell et al. (1970) , there was no evidence of any change in cardiac output with either drug. The absence of significant changes in blood pressure and heart rate after terbutaline and in blood pressure with reduced heart rate (P<0C05) after salbutamol are consistent with the cardiac output findings. (Harris, 1970 (Harris, , 1972 , who suggested that it is the /82 pulmonary vasodilator effect which is responsible by interfering with the homeostatic mechanism whereby blood flow is reduced to underventilated areas. This concept appears to be substantiated by the absence of change in cardiac output in the present study. Having now reached the state of obtaining potent /8-adrenergic stimulating bronchodilators with wide separation of /81 and /32 effects, the next stage of development might be the separation of the /82 bronchodilator and vasodilator effects (in which case the latter might become known as ,/3 effect).
The results presented suggest that terbutaline and salbutamol are equally effective bronchodilators when administered by pressurized aerosol, without cardiac effects, in the dosage used, and that terbutaline is less likely than salbutamol to cause increased hypoxaemia.
